Diagnostic sensitivity analysis of the immunochemical fecal occult blood test for colorectal cancers
Not Applicable
- Conditions
- Colorectal cancer
- Registration Number
- JPRN-UMIN000009570
- Lead Sponsor
- ational Cancer Center Hospital, Tokyo, Japan
- Brief Summary
FIT had significantly lower sensitivity for proximal or early CRCs, even using two stool samples. The results of our findings on screening effectiveness need further study.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 636
Inclusion Criteria
Not provided
Exclusion Criteria
Patient who has synchronous colorectal cancers, IBD and GI cancers.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Diagnostic sensitivity of immunochemical fecal occult blood test (FIT) for colorectal cancers based on the location, staging, tumor size and macroscopic types.
- Secondary Outcome Measures
Name Time Method False positive and negative rates of immunochemical fecal occult blood test (FIT) for colorectal cancers based on the location, staging, tumor size and macroscopic types.